Aisel utilizes an AI-driven platform to conduct initial background assessments in mental health care, generating detailed reports based on established psychiatric methodologies. This enables psychiatrists to begin sessions with comprehensive insights, enhancing the quality of patient interactions.
Funding
$10K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Psychiatrists often spend valuable session time gathering background information from patients, which can delay the start of therapy and reduce the time available for in-depth discussion and treatment planning. This inefficient process can lead to incomplete assessments and hinder the development of effective treatment strategies.
Solution
Aisel offers an AI-powered platform designed to streamline initial mental health assessments, allowing psychiatrists to begin sessions with comprehensive patient insights. The platform automates the background assessment process using established psychiatric methodologies, generating detailed reports that summarize key patient information. By providing psychiatrists with readily available and structured data, Aisel enables more informed and efficient session starts, ultimately enhancing the quality of patient interactions and treatment outcomes.
Target Audience
The primary target audience is psychiatrists and other mental health professionals seeking to improve the efficiency and effectiveness of their patient assessment process.
Features
- AI-driven analysis of patient-provided information based on psychiatric methodologies
- Automated generation of detailed assessment reports for psychiatrists
- Secure and compliant data handling to protect patient privacy
- Integration with existing electronic health record (EHR) systems